The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics.
WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version.
The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal.
WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%.
Britain's contentious plan to send some migrants to Rwanda hits a hurdle in Parliament
Attend flag ceremony or miss key math exam, Hong Kong student told — Radio Free Asia
Republican AGs attack Biden's EPA for pursuing environmental discrimination cases
Justice Department ramps up efforts to reduce violent crime with gun intel center
Emma Roberts reveals the $4,500 gift she gave an ex
Hush money trial: Trump's lawyers say Stormy Daniels refused subpoena outside Brooklyn bar
Arakan Army attacks another junta border outpost in western Myanmar — Radio Free Asia
Meet TikTok's NEWEST queen bee Leah Halton: Stunning Australian model, 23, is set to become the most
Salvador Perez's homer lifts Royals over White Sox 4
Rybakina, Vondroušová into Stuttgart quarters while Jabeur out
Capitals top prospect Ryan Leonard is returning to Boston College